Synovate Healthcare, the global specialist healthcare market research arm of Synovate, has appointed Paul Villa to the role of senior vice president of payer and market access research for its specialist healthcare research division.
Villa joins from global research-based consultancy firm Genactis, where he held the role of vice president responsible for leading US pricing and reimbursement projects. Villa brings vast knowledge of the US payer market to Synovate Healthcare, along with detailed knowledge of multiple therapy areas. He also has experience in the commercialisation and pricing of products in managed markets, which he gained in a previous marketing consultancy role.
Bob Douglas, global head of Synovate Healthcare said: "Paul's hands-on professional style and extensive and varied experience both agency and client-side make him a valuable addition to our team. I look forward to working with Paul to grow our payer research capabilities both in the US and globally."
Villa will lead a dedicated payer and market access research team and will take responsibility for delivering research-based guidance to clients on market access issues.
Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...